Showing results (1-10 of 350) with videos related to
Sort By:
Pageof 35
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1989
Second generation model for prednisolone pharmacodynamics in the ratA I Nichols, F D Boudinot, W J JuskoJournal of Pharmaceutical Sciences|June 1, 1984
Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysisF D Boudinot, W J JuskoJournal of Steroid Biochemistry|September 1, 1984
Plasma protein binding interaction of prednisone and prednisoloneF D Boudinot, W J JuskoJournal of Pharmacokinetics and Biopharmaceutics|October 1, 1986
Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized ratsF D Boudinot, W J JuskoJournal of Pharmacokinetics and Biopharmaceutics|October 1, 1986
Receptor-mediated pharmacodynamics of prednisolone in the ratF D Boudinot, R D'Ambrosio, W J JuskoJournal of Pharmacokinetics and Biopharmaceutics|June 1, 1990
Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimenA I Nichols, W J JuskoAntimicrobial Agents and Chemotherapy|March 1, 1982
Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairmentA Mangione, F D Boudinot, R M Schultz, et al.Biochemical Pharmacology|June 15, 1985
Protein binding of oxazepam and its glucuronide conjugates to human albuminF D Boudinot, C A Homon, W J Jusko, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Pharmacokinetics and pharmacodynamics of prednisolone in obese ratsA I Nichols, R D'Ambrosio, N A Pyszczynski, et al.European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1995
Non-linear renal and biliary clearances of antiviral polyoxometalates in ratsL Ni, F D BoudinotPageof 35